Rallybio Corporation (RLYB) Revenue History
Annual and quarterly revenue from 2019 to present
RLYB Revenue Over Time (2019–2025)
RLYB Revenue Growth History
1 of 1 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- +34.9%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $212K | +0.0% |
| Q4 2025 | $222K | +484.2% |
| Q3 2025 | $212K | -29.1% |
| Q2 2025 | $212K | -29.1% |
| Q1 2025 | $212K | — |
| Q4 2024 | $38K | -83.3% |
| Q3 2024 | $299K | — |
| Q2 2024 | $299K | — |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
RLYB's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
RLYB Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 29, 2026, Rallybio Corporation (RLYB) generated trailing twelve-month (TTM) revenue of $858,000, reflecting slight decline in growth of +0.0% year-over-year. The most recent quarter (Q1 2026) recorded $212,000 in revenue, down 4.5% sequentially.
Historical Growth Trajectory
RLYB's historical revenue data shows various trends over time. Rallybio Corporation's highest annual revenue of $858,000 was recorded in 2025, an all-time high.
Revenue by Segment
RLYB's revenue is primarily driven by Collaboration And License Revenue (52%), and License (48%). With over half of revenue concentrated in Collaboration And License Revenue, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including KYMR (-12.6% YoY), and ARQT (+95.3% YoY) — RLYB has underperformed the peer group in revenue growth. Compare RLYB vs KYMR →
RLYB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RLYBCurrent | $858,000 | +0.0% | - | -3270.9% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 ARQT | $376M | +95.3% | - | -3.3% |
RLYB Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $858K | +34.9% | $766K | 89.3% | $-28,064,000 | -3270.9% |
| 2024 | $636K | - | $636K | 100.0% | $-60,496,000 | -9511.9% |
| 2023 | $0 | - | $-150,000 | - | $-78,932,000 | - |
| 2022 | $0 | - | $-167,000 | - | $-67,884,000 | - |
| 2021 | $0 | - | $-109,000 | - | $-45,648,000 | - |
| 2020 | $0 | - | $-62,030 | - | $-25,303,000 | - |
| 2019 | $0 | - | $-26,344 | - | $-17,642,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
RLYB — Frequently Asked Questions
Quick answers to the most common questions about buying RLYB stock.
Is RLYB's revenue growth accelerating or slowing?
RLYB TTM revenue: $858000.00. YoY growth: +0.0%. 5-year CAGR: N/A.
What is RLYB's revenue history from 2019 to 2026?
Rallybio Corporation (RLYB) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $858000.00, growing at +0.0% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is RLYB's long-term revenue growth rate (CAGR)?
Rallybio Corporation's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +0.0% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for RLYB.
Why does RLYB's quarterly revenue fluctuate?
RLYB quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Rallybio Corporation's revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is RLYB's revenue distributed by segment?
RLYB reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does RLYB's revenue compare to industry peers?
Rallybio Corporation (RLYB) with TTM revenue of $858000.00 and +0.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.